BRAINTREE, Mass., Feb. 6, 2013 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that Chris Lindop, CFO and VP, Business Development, will present at the Leerink Swann 2013 Global Healthcare Conference in New York on February 13, 2013 at 3:00pm Eastern time.
The public may access Mr. Lindop's presentation live via webcast at http://leerink.metameetings.com/webcasts/healthcare13/directlink?p=167.
About Haemonetics Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.CONTACT: Gerry Gould, VP-Investor Relations Tel. (781) 356-9402 email@example.com Alt. (781) 356-9613 SOURCE Haemonetics Corporation
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts